Bisphosphonate Binding Affinity Affects Drug Distribution in Both Intracortical and Trabecular Bone of Rabbits
- 886 Downloads
Differences in the binding affinities of bisphosphonates for bone mineral have been proposed to determine their localizations and duration of action within bone. The main objective of this study was to test the hypothesis that mineral binding affinity affects bisphosphonate distribution at the basic multicellular unit (BMU) level within both cortical and cancellous bone. To accomplish this objective, skeletally mature female rabbits (n = 8) were injected simultaneously with both low- and high-affinity bisphosphonate analogs bound to different fluorophores. Skeletal distribution was assessed in the rib, tibia, and vertebra using confocal microscopy. The staining intensity ratio between osteocytes contained within the cement line of newly formed rib osteons or within the reversal line of hemiosteons in vertebral trabeculae compared to osteocytes outside the cement/reversal line was greater for the high-affinity compared to the low-affinity compound. This indicates that the low-affinity compound distributes more equally across the cement/reversal line compared to a high-affinity compound, which concentrates mostly near surfaces. These data, from an animal model that undergoes intracortical remodeling similar to humans, demonstrate that the affinity of bisphosphonates for the bone determines the reach of the drugs in both cortical and cancellous bone.
KeywordsAnti-remodeling Skeletal distribution Drug accumulation Fluorescent bisphosphonate
The authors thank the following individuals for their technical contributions to the project: Dr. Keith Condon (tissue processing), Drs. Malgorzata Kamocka and Ken Dunn (technical assistance with confocal microscopy set-up), and Carrie Pell and staff (animal care/dosing). The confocal microscopy was performed within the Indiana Center for Biological Microscopy Resources. Funding for this study was provided by a grant from Warner Chilcott.
- 2.Ebetino FH, Hogan A-ML, Sun S, Tsoumpra MK, Duan X, Triffitt JT, Kwaasi AA, Dunford JE, Barnett BL, Oppermann U, Lundy MW, Boyde A, Kashemirov BA, McKenna CE, Russell RGG (2011) The relationship between the chemistry and biological activity of the bisphosphonates. Bone 49:20–33PubMedCrossRefGoogle Scholar
- 5.Roelofs AJ, Coxon FP, Ebetino FH, Lundy MW, Henneman ZJ, Nancollas GH, Sun S, Blazewska KM, Lynn FBJ, Kashemirov BA, Khalid AB, McKenna CE, Rogers MJ (2009) Fluorescent risedronate analogs reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo. J Bone Miner Res 25:606–616CrossRefGoogle Scholar
- 9.Roelofs A, Stewart CA, Sun S, Blazewska K, Kashemirov BA, McKenna CE, Russell RGG, Rogers MJ, Lundy MW, Ebetino FH, Coxon FP (2011) Influence of bone affinity on the skeletal distribution of fluorescently-labeled bisphosphonates in vivo. J Bone Miner Res (in press)Google Scholar
- 14.Sun S, Blazewska KM, Kashemirov BA, Roelofs AJ, Coxon FP, Rogers MJ, Ebetino FH, McKenna MJ, McKenna CE (2011) Synthesis and characterization of novel fluorescent nitrogen-containing bisphosphonate imaging probes for bone active drugs. Phosphorus Sulfur Silicon Relat Elem 186:970–971PubMedCrossRefGoogle Scholar
- 18.Abramoff MD, Magalhaes P, Ram S (2004) Image processing with ImageJ. Biophoton Int 11:36–43Google Scholar